IMMERSION CORPORATION (IMMR)

US4525211078 - Common Stock

9.09  +0.14 (+1.62%)

After market: 9.05 -0.04 (-0.44%)

Fundamental Rating

7

IMMR gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 31 industry peers in the Technology Hardware, Storage & Peripherals industry. IMMR scores excellent points on both the profitability and health parts. This is a solid base for a good stock. IMMR scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make IMMR a good candidate for value and quality investing.



7

1. Profitability

1.1 Basic Checks

IMMR had positive earnings in the past year.
In the past year IMMR had a positive cash flow from operations.
IMMR had positive earnings in 4 of the past 5 years.
Of the past 5 years IMMR 4 years had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 18.13%, IMMR belongs to the top of the industry, outperforming 93.55% of the companies in the same industry.
IMMR has a better Return On Equity (22.02%) than 90.32% of its industry peers.
IMMR's Return On Invested Capital of 11.54% is fine compared to the rest of the industry. IMMR outperforms 70.97% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IMMR is significantly below the industry average of 15.77%.
The last Return On Invested Capital (11.54%) for IMMR is above the 3 year average (9.10%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.13%
ROE 22.02%
ROIC 11.54%
ROA(3y)13%
ROA(5y)5.72%
ROE(3y)15.61%
ROE(5y)6.28%
ROIC(3y)9.1%
ROIC(5y)N/A

1.3 Margins

IMMR has a better Profit Margin (62.75%) than 100.00% of its industry peers.
IMMR's Profit Margin has improved in the last couple of years.
IMMR has a better Operating Margin (44.25%) than 100.00% of its industry peers.
IMMR's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 44.25%
PM (TTM) 62.75%
GM N/A
OM growth 3Y94.23%
OM growth 5Y2.01%
PM growth 3Y78.19%
PM growth 5Y15.41%
GM growth 3YN/A
GM growth 5YN/A

9

2. Health

2.1 Basic Checks

IMMR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for IMMR has been reduced compared to 1 year ago.
The number of shares outstanding for IMMR has been increased compared to 5 years ago.
There is no outstanding debt for IMMR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 5.41 indicates that IMMR is not in any danger for bankruptcy at the moment.
The Altman-Z score of IMMR (5.41) is better than 83.87% of its industry peers.
IMMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.41
ROIC/WACC0.95
WACC12.19%

2.3 Liquidity

IMMR has a Current Ratio of 6.44. This indicates that IMMR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 6.44, IMMR belongs to the top of the industry, outperforming 93.55% of the companies in the same industry.
IMMR has a Quick Ratio of 6.44. This indicates that IMMR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 6.44, IMMR belongs to the top of the industry, outperforming 93.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.44
Quick Ratio 6.44

5

3. Growth

3.1 Past

IMMR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.28%, which is quite impressive.
Measured over the past years, IMMR shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.60% on average per year.
IMMR shows a strong growth in Revenue. In the last year, the Revenue has grown by 338.29%.
IMMR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -21.11% yearly.
EPS 1Y (TTM)58.28%
EPS 3Y47.44%
EPS 5Y-9.6%
EPS Q2Q%217.86%
Revenue 1Y (TTM)338.29%
Revenue growth 3Y3.61%
Revenue growth 5Y-21.11%
Sales Q2Q%650.44%

3.2 Future

The Earnings Per Share is expected to decrease by -33.01% on average over the next years. This is quite bad
Based on estimates for the next years, IMMR will show a very strong growth in Revenue. The Revenue will grow by 363.38% on average per year.
EPS Next Y75.07%
EPS Next 2Y-33.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1039.86%
Revenue Next 2Y363.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

8

4. Valuation

4.1 Price/Earnings Ratio

IMMR is valuated cheaply with a Price/Earnings ratio of 7.27.
Based on the Price/Earnings ratio, IMMR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.73. IMMR is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 16.20, which indicates a correct valuation of IMMR.
IMMR's Price/Forward Earnings is on the same level as the industry average.
IMMR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.83.
Industry RankSector Rank
PE 7.27
Fwd PE 16.2

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IMMR indicates a rather cheap valuation: IMMR is cheaper than 100.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IMMR indicates a rather cheap valuation: IMMR is cheaper than 96.77% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.23
EV/EBITDA 0.66

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IMMR has a very decent profitability rating, which may justify a higher PE ratio.
IMMR's earnings are expected to decrease with -33.01% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y-33.01%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

IMMR has a Yearly Dividend Yield of 2.01%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.91, IMMR pays a better dividend. On top of this IMMR pays more dividend than 87.10% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.24, IMMR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.01%

5.2 History

IMMR has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

10.14% of the earnings are spent on dividend by IMMR. This is a low number and sustainable payout ratio.
DP10.14%
EPS Next 2Y-33.01%
EPS Next 3YN/A

IMMERSION CORPORATION

NASDAQ:IMMR (12/20/2024, 8:18:24 PM)

After market: 9.05 -0.04 (-0.44%)

9.09

+0.14 (+1.62%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)11-22 2024-11-22/amc
Earnings (Next)N/A N/A
Inst Owners64.28%
Inst Owner Change-2.96%
Ins Owners5.09%
Ins Owner Change9.19%
Market Cap292.52M
Analysts82.5
Price Target14.03 (54.35%)
Short Float %10.74%
Short Ratio4.43
Dividend
Industry RankSector Rank
Dividend Yield 2.01%
Dividend Growth(5Y)N/A
DP10.14%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-10 2025-01-10 (0.245)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)95.24%
Min Revenue beat(2)23.76%
Max Revenue beat(2)166.71%
Revenue beat(4)3
Avg Revenue beat(4)51.28%
Min Revenue beat(4)-11.8%
Max Revenue beat(4)166.71%
Revenue beat(8)5
Avg Revenue beat(8)32.07%
Revenue beat(12)7
Avg Revenue beat(12)20.51%
Revenue beat(16)9
Avg Revenue beat(16)15.2%
PT rev (1m)0%
PT rev (3m)10%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 7.27
Fwd PE 16.2
P/S 4.14
P/FCF 6.23
P/OCF 6.23
P/B 1.45
P/tB 1.45
EV/EBITDA 0.66
EPS(TTM)1.25
EY13.75%
EPS(NY)0.56
Fwd EY6.17%
FCF(TTM)1.46
FCFY16.06%
OCF(TTM)1.46
OCFY16.06%
SpS2.2
BVpS6.26
TBVpS6.26
PEG (NY)0.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 18.13%
ROE 22.02%
ROCE 14.58%
ROIC 11.54%
ROICexc 69.78%
ROICexgc 69.78%
OM 44.25%
PM (TTM) 62.75%
GM N/A
FCFM 66.46%
ROA(3y)13%
ROA(5y)5.72%
ROE(3y)15.61%
ROE(5y)6.28%
ROIC(3y)9.1%
ROIC(5y)N/A
ROICexc(3y)48.9%
ROICexc(5y)N/A
ROICexgc(3y)48.9%
ROICexgc(5y)N/A
ROCE(3y)11.5%
ROCE(5y)N/A
ROICexcg growth 3Y84.52%
ROICexcg growth 5YN/A
ROICexc growth 3Y84.52%
ROICexc growth 5Y-44.16%
OM growth 3Y94.23%
OM growth 5Y2.01%
PM growth 3Y78.19%
PM growth 5Y15.41%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 149.87%
Profit Quality 105.91%
Current Ratio 6.44
Quick Ratio 6.44
Altman-Z 5.41
F-Score6
WACC12.19%
ROIC/WACC0.95
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)109.51%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.28%
EPS 3Y47.44%
EPS 5Y-9.6%
EPS Q2Q%217.86%
EPS Next Y75.07%
EPS Next 2Y-33.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)338.29%
Revenue growth 3Y3.61%
Revenue growth 5Y-21.11%
Sales Q2Q%650.44%
Revenue Next Year1039.86%
Revenue Next 2Y363.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.9%
EBIT growth 3Y101.23%
EBIT growth 5Y-19.52%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y97.38%
FCF growth 3YN/A
FCF growth 5Y-21.67%
OCF growth 1Y95.09%
OCF growth 3Y909.9%
OCF growth 5Y-21.68%